← Back to Search

Partners at Meals for Alzheimer's Dementia (PAM Trial)

N/A
Waitlist Available
Led By Teresa Kelechi
Research Sponsored by Medical University of South Carolina
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 6 months
Awards & highlights

PAM Trial Summary

This trial is testing a new intervention to help people with dementia and their caregivers during mealtimes. The intervention will be delivered by trained volunteers in respite centers, with the goal of improving nutrition and behavior during mealtimes.

Eligible Conditions
  • Alzheimer's Dementia
  • Weight Loss

PAM Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Weight maintenance

PAM Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Treatment - Partners at Meals (PAM)Experimental Treatment1 Intervention
People with dementia (PWD) often lose weight and suffer subsequent health issues: the goal of this intervention is to improve or maintain weight of a PWD, and to improve or maintain food intake. A train-the-trainer intervention is used with volunteers in Respite Care Centers who partner with family caregivers of PWD. Designed to be personalized to the PWD and focusing on his/her existing strengths and compensating for his/her deficits in mealtime management, sessions occur initially (1 hr) and every month (~30 mins) to reinforce key areas of behavioral or environmental change. Samsung tablets are used initially and then monthly (x5) to record mealtimes in the home, and are reviewed by the volunteer with the family member at the monthly session to discuss areas where changes could be made.
Group II: Enhanced Usual Condition (EUC)Placebo Group1 Intervention
In the non-treatment respite care centers, an Enhanced Usual Condition will be delivered to caregivers of People with Dementia (PWD). This program consists of enhanced training in caregiving using components from a module of the evidence-based Savvy Caregiver program (K. Hepburn) given in a group setting with opportunity for a question and answer period; the program is given for new enrollees and every 6 months. The PI (EJA), the nutritionist (KM) or the Program Manager (MCP) will lead these groups. Weight of the PWD is measured initially and monthly (x5); amount of food consumed will be measured using the Samsung tablets, also initially and monthly (x5).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Partners at Meals
2017
N/A
~130

Find a Location

Who is running the clinical trial?

Medical University of South CarolinaLead Sponsor
932 Previous Clinical Trials
7,394,135 Total Patients Enrolled
Teresa KelechiPrincipal InvestigatorMUSC College of Nursing

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the uppermost participant limit for this medical experiment?

"Affirmative. Clinicaltrials.gov attests that recruitment for this clinical trial, which was originally posted on August 15th 2017, is still active and needs 180 people from 1 locale to partake."

Answered by AI

Has the enrollment period for this experiment opened up yet?

"Clinicaltrials.gov data indicates that this clinical trial is seeking candidates at present, having been initially posted on August 15th 2017 and last modified on July 25th 2022."

Answered by AI
~16 spots leftby Apr 2025